Beneficial effect of succinic acid monoethyl ester on erythrocyte membrane bound enzymes and antioxidant status in streptozotocin-nicotinamide induced type 2 diabetes

Chemico-Biological Interactions

Volumn 169, Issue 1, 2007, Pages 15-24

  Pari, L ^a   Saravanan, R ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Antioxidants; ATPases; Lipid peroxidation; Nicotinamide; Protein glycation; Streptozotocin; Succinic acid monoethyl ester; Type 2 diabetes

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (MAGNESIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CATALASE; ERYTHROCYTE ENZYME; GLUCOSE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN; HYDROPEROXIDE; INSULIN; NICOTINAMIDE; STREPTOZOCIN; SUCCINIC ACID DERIVATIVE; SUCCINIC ACID ETHYL ESTER; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; DRUG EFFECT; ENZYME ACTIVITY; ERYTHROCYTE MEMBRANE; LIPID PEROXIDATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RAT; STREPTOZOCIN DIABETES; TREATMENT DURATION;

ADENOSINE TRIPHOSPHATASES; ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; ERYTHROCYTE MEMBRANE; GLYCOSYLATION; HEMOGLOBINS; HYDROGEN PEROXIDE; INSULIN; LIPID PEROXIDATION; MALE; NIACINAMIDE; RATS; RATS, WISTAR; STREPTOZOCIN; SUCCINATES; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

RATTUS;

EID: 34447268712     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2007.04.010     Document Type: Article

References (66)

1. King H., Aubert R.E., and Herman W.H. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21 (1998) 1414-1431
2. Watala C., Golanski J., Boncler M.A., Pietrucha R., and Gwozdzinski K. Membrane lipid fluidity of blood platlets: a comman denominator that underlies the opposing actions of various agents that affect platlet activation in whole blood. Platelets 9 (1993) 315-327
3. Augustyniak K., Zavodnik I., Palecz D., Szosland K., and Bryszewska M. The effect of oxidizing agent and diabetes mellitus on the human red blood cell membrane potential. Clin. Biochem. 29 (1996) 283-286
4. Zavodnik I.B., Piasecka A., Szosaland K., and Bryszewska M. Human red blood cell membrane potential and fluidity in glucose solution. Scand. J. Clin. Lab. Invest. 57 (1997) 59-63
5. Picton S.F., Flatt P.R., and Mcclenghan N.H. Differntial acute and long-term actions of succinic acid monomethyl ester exposure on insulin secreting Brain-BD 11 cells. Int. J. Exp. Diabetes Res. 2 (2001) 19-27
6. Fahiens L.A., MacDonald M.J., Kmiotek E.H., Mertzo R.J., and Fahien C.M. Regulation of insulin release by factors that also modify glutamate dehydrogenase. J. Biol. Chem. 263 (1988) 13610-13614
7. MacDonald M.J., and Fahien L.A. Glyceraldehyde phosphate and methyl esters of succinic acid two new potent insulin secretagogues. Diabetes 37 (1988) 997-999
8. Alarcon C., and Wicksteed B. Succinate is a preferential metabolic stimulus-coupling signal for glucose-induced proinsulin biosynthesis translation. Diabetes 51 (2002) 2496
9. Zawalich W.S., and Zawalich K.C. Biochemical mechanisms involved in monomethyl succinate-induced insulin secretion. Endocrinology 131 (1992) 649-654
10. Juan A., Martinez G., Maria L., Penacarrillo V., Valverde I., Bjorkling F., and Malaisse W.J. Potentiation of the insulinotropic and hypoglycemic action of gliquidone by succinic acid esters. Eur. J. Pharmacol. 325 (1998) 65-68
11. Akkan A.G., and Malaisse W.J. Iterative pulse administration of succinic acid monomethyl ester to streptozotocin diabetic rats. Diabetes Res. 23 (1993) 55-63
12. Decio L., Eizirik D.L., Welsh N., Niemann A., Velloso L.A., and Malaisse W.J. Succinic acid monomethyl ester protects rat pancreatic islet secretory potential against interleukin-lβ (IL-1β) without affecting glutamate decarboxylase expression or nitric oxide production. FEBS Lett. 337 (1994) 298-302
13. Decio L., Eizirik D.l., Delaney C.A., Green M.H.L., Cunningham J.M., Thorpe J.R., Pipeleers D.S., Hellerstrom C., and Green I.C. Nitric oxide donors decrease the function and survival of human pancreatic islets. Mol. Endocrinol. 118 (1996) 71-83
14. Uchigata Y., Yamamoto H., Nagai H., and Okamoto H. Effect of poly (ADP-ribose) synthetase inhibitor administration to rats before and after injection of alloxan and streptozotocin on islet proinsulin synthesis. Diabetes 32 (1983) 316-318
15. Novelli M., Fabregat M.E., Fernandez-Alvarez J., Gomis R., and Masiello: P. Metabolic and functional studies on isolated islets in a new rat model of type 2 diabetes. Mol. Cell. Endocrinol. 175 (2001) 57-66
16. Pari L., and Saravanan R. Succinic acid monoethyl ester [EMS] and metformin regulates carbohydrate metabolic enzymes and improves glycemic control in streptozotocin-nicotinamide induced type 2 diabetic rats. IJPT 4 (2005) 132-137
17. Saravanan R., and Pari L. Succinic acid monoethyl ester prevents oxidative stress in sterptozotocin-nicotinamide induced type 2 diabetic rats. J. Basic Clin. Physiol. Pharmacol. 17 (2006) 115-132
18. Saravanan R., and Pari L. Succinic acid monoethyl ester, a novel insulinotropic agent: effect on lipid composition and lipid peroxidation in streptozotocin-nicotinamide induced type 2 diabetic rats. Mol. Cell. Biochem. 286 (2006) 53-59
19. Pari L., and Saravanan R. Effect of succinic acid monoethyl ester on plasma and tissue glycoproteins in streptozotocin-nicotinamide induced diabetic rats. J. Appl. Biomed. 4 (2006) 187-196
20. Masiello P., Broca C., Gross R., Roye M., Manteghetti M., Hillaire-Buys D., Novelli M., and Ribes G. Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 47 (1998) 224-229
21. Yanardag R., Ozsoy-Sacan O., Bolkent S., Orak H., and Karabulut-Bulan O. Protective effects of metformin treatment on the liver injury of streptozotocin-diabetic rats. Hum. Exp. Toxicol. 24 (2005) 129-135
22. Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann. Clin. Biochem. 6 (1969) 24-27
23. Drabkin D.L., and Austin J.M. Spectrophotometric constants for common hemoglobin derivatives in human, dog and rabbit blood. J. Biol. Chem. 98 (1932) 719-733
24. Sudhakar Nayak S., and Pattabiraman T.N. A new colorimetric method for the estimation of glycosylated hemoglobin. Clin. Chem. Acta 109 (1981) 267-274
25. Bannon P. Effect of pH on the elimination of the labile fraction of glycosylated hemoglobin. Clin. Chem. 28 (1982) 2183
26. Dodge J.T., Mitchell G., and Hanaban D.J. The preparation and chemical characteristics of haemoglobin free ghosts of human red cells. Arch. Biochem. Biophys. 100 (1963) 119-130
27. Quist E.H. Regulation of erythrocyte membrane shape by calcium ions. Biochem. Biophys. Res. Commun. 92 (1980) 631-637
28. Evans D.J. Membrane adenosine triphosphate of E. coli activation by calcium ions inhibition by monovalent cations. J. Bacteriol. 100 (1969) 914
29. Fiske C.H., and Subbarow Y. The colorimetric determination of phosphorus. J. Biol. Chem. 66 (1925) 375-400
30. Bonting S.L. In: Bittar C., and Eeeditors W. (Eds). Membrane and Ion Transport (1970), Interscience, London 25-28
31. Hjerken S., and Pan H. Purification and characterization of two forms of a low affinity calcium ion ATPase from erthrocyte membrane. Biochem. Biophys. Acta 728 (1983) 281-288
32. Ohinishi T., Suzuki T., Suzuki Y., and ozwa K. A comparative study of plasma membrane magnesium ion ATPase activity in normal, regenerating and malignant cells. Biochim. Biophys. Acta 684 (1982) 67-74
33. Fraga C.G., Leibouitz B.E., and Toppel A.L. Lipid peroxidation measured as TBARS in tissue slices: characterization and comparision with homogenates and microsomes. Free Radic. Biol. Med. 4 (1988) 155-161
34. Donnan S.K. The thiobarbituric acid test applied to tissues from rats treated in various ways. J. Biol. Chem. 182 (1950) 415-419
35. Jiang Z.Y., Hunt J.V., and Wolff S.D. Ferrous sulphate oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low-density lipoprotein. Anal. Biochem. 202 (1992) 384-389
36. Kakkar P., Das B., and Viswanathan P.N. A modified spectrophotometric assay of superoxide dismutase. Indian J. Biochem. Biophys. 21 (1972) 130-132
37. Sinha K.A. Colorimetric assay of catalase. Ann. Biochem. 47 (1972) 389-394
38. Rotruck J.J., Pope A.L., Ganther H.E., and Swanson A.B. Selenium: biochemical role as a component of glutathione peroxidase. Science 179 (1973) 588-590
39. Habig W.H., Pabst M.J., and Jakpoby W.B. Glutathione transferase, a first enzymatic step in mercaturic acid formation. J. Biol. Chem. 249 (1974) 7130-7139
40. Roe J.H., and Kuether C.A. Detection of ascorbic acid in whole blood and urine through 2,4-DNPH derivative of dehydroascorbic acid. J. Biol. Chem. 147 (1943) 399-407
41. Baker H., Frankel O., De Angelis B., and Feingold S. Plasma α-tocopherol in man at various time intervals after ingesting free or acetylated tocopherol. Nutr. Rep. Int. 21 (1980) 531-536
42. Ellman G.L. Tissue sulphydryl groups. Arch. Biochem. Biophys. 82 (1959) 70-77
43. Beutler E., Duron O., and Kelly B.M. Improved method for the determination of blood glutathione. J. Lab. Clin. Med. 61 (1963) 882-888
44. Duncan B.D. Multiple range tests for correlated and heteroscedastic means. Biometrics 13 (1957) 359-364
45. Brownlee M., Vlassara H., and Cerami A. Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann. Int. Med. 101 (1984) 527-533
46. Hunt J.V., and Wolff S.P. Is glucose the sole source of tissue browning in diabetes mellitus?. FEBS Lett. 269 (1990) 258-260
47. Penckofer S., Schwertz D., and Florczak K. Oxidative stress and cardiovascular disease in type 2 diabetes: the role of antioxidants and prooxidants. J. Cardiovasc. Nurs. 16 (2002) 68-85
48. Malaisse W.J. The esters of carboxylic nutrients as insulinotropic tools in non-insulin-dependent diabetes mellitus. Gen. Pharmac. 26 (1995) 1133-1141
49. Maechler P., and Wollheim C.B. Mitochondrial signals in glucose-stimulated insulin secretion in the beta cell. J. Physiol. 529 (2000) 49-56
50. Ainscow E.K., Zhao C., and Rutter G.A. Acute over expression of lactate dehydrogenase-A perturbs beta-cell mitochondrial metabolism and insulin secretion. Diabetes 49 (2000) 1149-1155
51. Kumar P.A., Haseeb A., Suryanarayana P., Ehtesham N.Z., and Reddy G.B. Elevated expression of alpha A- and alpha B-crystallins in streptozotocin-induced diabetic rat. Arch. Biochem. Biophys. 444 (2005) 77-83
52. Cussimanio B.L., Booth A.A., Todd P., Hudson B.G., and Khalifah R.G. Unusual susceptibility of heme proteins to damage by glucose during non-enzymatic glycation. Biophys. Chem. 105 (2003) 743-755
53. Wolffenbuttel B.H., Giordino D., Founds H.W., and Bucala R. Long-term assessment of glucose control by hemoglobin-AGE measurement. Lancet 347 (1996) 513-515
54. Sena S., Karb M., Roya A., and Chakrabortia A.S. Effect of nonenzymatic glycation on functional and structural properties of hemoglobin. Biophys. Chem. 113 (2005) 289-298
55. Pawlak W., Kedziora J., Zolynski K., Kedziora-Kornatowska K., Blaszczyk J., Witkowski P., and Zieleniewski J. Effect of long term bed rest in men on enzymatic antioxidative defense and lipid peroxidation in erythrocytes. J. Gravit. Physiol. 5 1 (1998) 163-164
56. Zhang E.Y., and Swaan P.W. Determinition of membrane protein glycation in diabetic tissue. AAPS Pharmsci. 20 (1999) 1-7
57. Del Maestro R.F. An approach to free radicals in medicine and biology. Acta. Physiol. Scand. 492 (1980) 153-168
58. Sun F., Iwaguchi K., Shudo R., Nagaki Y., Tanaka K., Ikeda K., et al. Change in tissue concentrations of lipid hydroperoxides, vitamin C and vitamin E in rats with streptozotocin-induced diabetes. Clin. Sci. 96 (1999) 185-190
59. Yu B.P. Cellular defenses against damage from reactive oxygen species. Physiol. Rev. 74 (1994) 136-162
60. ++ ATPase activity of the intestinal brush border membrane. Biochem. Biophys. Acta 984 (1989) 151-157
61. Mamta M.K., and Surendra S.K. Altered kinetic attributes of Na, K-ATPase activity in kidney, brain and erthyrocyte membranes in alloxan diabetic rats. Indian J. Exp. Biol. 30 (1992) 26-32
62. +-ATPase activity in the heart of streptozotocin-diabetic rats. Chem. Biol. Interact. 162 (2006) 157-164
63. + ATPase isoenzymes in the left ventricle of diabetic rat heart: effect on insulin treatment. Diabetes Metab. 25 (1999) 32-40
64. Fairhurst S., Barber D.J., Clark B., and Horton A.A. Studies on paracetamol induced lipid peroxidation. Toxicology 23 (1982) 249-259
65. Ramana devi C.H.V., Hema prasad M., Padmaja reddy T., and Reddy P.P. Glycosylation of hemoglobin and erythrocyte membraneproteins mediated changes in osmotic fragility of erthrocytes. Indian J. Med. Sci. 51 (1997) 5-9
66. 2+ ATPase activity after glycosylation of erythrocyte membranes in vivo and in vitro. Diabetes 39 (1990) 707-711